FDA Clears Blood Test to Support Alzheimer’s Disease Assessment
The FDA has cleared a pTau217 blood test to support Alzheimer’s disease…
“TRUE LEADERSHIP IN HEALTHCARE IS DEFINED BY STEWARDSHIP, NOT JUST PERFORMANCE”
In this exclusive interview, Isabel Afonso, CEO of Arcera Life Sciences, discusses…
It Starts With A Question: Is This Alzheimer’s?
Alzheimer’s Disease International (ADI) is opening this year’s World Alzheimer’s Month with…
AriBio Signs $600M Alzheimer’s Drug Deal with UAE-Based Arcera
A new chapter in Alzheimer’s disease treatment is being written with a…
Sanofi to acquire Vigil Neuroscience, Inc., adding a newinvestigational medicine to treat Alzheimer’s disease to theneurology pipeline
Sanofi announced today that it has entered into an agreement to acquire…
